Heart Disease Clinical Trials in Ohio

Showing 181-200 of 458 trials

Biomarkers of Acute Stroke in Clinic

NCT03897478

The proposed study will investigate the clinical use of the ISCDX test that may differentiate between diverse stroke etiologies as listed below: Aim 1: Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out, as defined by TOAST classification of subtypes of acute ischemic stroke. Aim 2: In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic.

Ischemic StrokeIschemiaAtrial Fibrillation+14 more

Ischemia Care LLC500 participantsStarted Apr 2019

Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

NCT00709865

The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.

Renal InsufficiencyCongestive Heart Failure

Biogen420 participantsStarted Jul 2008

Huntsville, Alabama, United States • Mobile, Alabama, United States • Fort Smith, Arkansas, United States +186 more locations

Biomarkers of Acute Stroke in Clinic

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Heart Disease Trials in Other Cities

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Statin Therapy for Ischemic and Nonischemic Cardiomyopathy

Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Genomic Response Analysis of Heart Failure Therapy in African Americans

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

Improving Quality by Maintaining Accurate Problems in the EHR

Family Health History in Diverse Care Settings (FHH)

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Other Conditions in Ohio